Perceptive Advisors’s Immunomedics Inc IMMU Stock Holding History

Perceptive Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-100,000	Closed	-$3.54M	–	152
2020 Q2	$3.54M	Buy	+100,000	New	+$2.92M	0.06%	100
2015 Q3	–	Sell	-700,000	Closed	-$2.84M	–	197
2015 Q2	$2.84M	Buy	700,000 +100,000	+17%	+$409K	0.17%	87
2015 Q1	$2.63M	Buy	+600,000	New	+$2.61M	0.2%	77

Perceptive Advisors's IMMU Position: Q4 2020 in Review

Perceptive Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 912,140 shares — an estimated $77.6M sold.

Perceptive Advisors first reported a position in IMMU in Q2 2013 and held it in 13 quarters. The position peaked at $77.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Perceptive Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Perceptive Advisors sold 912,140 Immunomedics Inc shares in Q4 2020, an estimated $77.6M.
Perceptive Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 13 quarters.
Perceptive Advisors's Immunomedics Inc position peaked at $77.6M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Perceptive Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.